$2500 | Single User
$5000 | Site License
$7500 | Global License

Cholera Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

Published by Global Data: 31 Dec 2018 | 230694 | In Stock

Introduction

Cholera Global Clinical Trials Review, H2, 2018

Summary

GlobalData's clinical trial report, “Cholera Global Clinical Trials Review, H2, 2018" provides an overview of Cholera clinical trials scenario. This report provides top line data relating to the clinical trials on Cholera. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for Cholera Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    GlobalData Clinical Trials Report Coverage 6

    Clinical Trials by Region 7

    Clinical Trials and Average Enrollment by Country 8

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

    Top Countries Contributing to Clinical Trials in Europe 12

    Top Countries Contributing to Clinical Trials in North America 13

    Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14

    Top Countries Contributing to Clinical Trials in Central and South America 15

    Clinical Trials by G7 Countries: Proportion of Cholera to Infectious Disease Clinical Trials 16

    Clinical Trials by Phase in G7 Countries 17

    Clinical Trials in G7 Countries by Trial Status 18

    Clinical Trials by E7 Countries: Proportion of Cholera to Infectious Disease Clinical Trials 19

    Clinical Trials by Phase in E7 Countries 20

    Clinical Trials in E7 Countries by Trial Status 21

    Clinical Trials by Phase 22

    In Progress Trials by Phase 23

    Clinical Trials by Trial Status 24

    Clinical Trials by End Point Status 25

    Subjects Recruited Over a Period of Time 26

    Clinical Trials by Sponsor Type 27

    Prominent Sponsors 28

    Top Companies Participating in Cholera Therapeutics Clinical Trials 30

    Prominent Drugs 32

    Clinical Trial Profile Snapshots 33

    Appendix 68

    Abbreviations 68

    Definitions 68

    Research Methodology 69

    Secondary Research 69

    About GlobalData 70

    Contact Us 70

    Source 70

List Of Tables
in Cholera Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Tables

Cholera Therapeutics, Global, Clinical Trials by Region, 2018* 7

Cholera Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 9

Cholera Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Cholera Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Cholera Therapeutics Clinical Trials, Europe, Top Countries, 2018* 12

Cholera Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Cholera Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2018* 14

Cholera Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Cholera to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16

Cholera Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Cholera Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Cholera to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 19

Cholera Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Cholera Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Cholera Therapeutics, Global, Clinical Trials by Phase, 2018* 22

Cholera Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 23

Cholera Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Cholera Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Cholera Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Cholera Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 27

Cholera Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 29

Cholera Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 31

Cholera Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

List Of Figures, Charts and Diagrams
in Cholera Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018]

List of Figures

Cholera Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Cholera Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Cholera Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Cholera Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Cholera Therapeutics Clinical Trials, Europe, Top Countries (%), 2018* 12

Cholera Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Cholera Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2018* 14

Cholera Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15

Proportion of Cholera to Infectious Disease Clinical Trials, G7 Countries (%), 2018* 16

Cholera Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Cholera Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Cholera to Infectious Disease Clinical Trials, E7 Countries (%), 2018* 19

Cholera Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 20

Cholera Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 21

Cholera Therapeutics, Global, Clinical Trials by Phase (%), 2018* 22

Cholera Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 23

Cholera Therapeutics, Global, Clinical Trials by Trial Status, 2018* 24

Cholera Therapeutics Clinical Trials, Global, by End Point Status, 2018* 25

Cholera Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 26

Cholera Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 27

Cholera Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 28

Cholera Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 30

Cholera Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 32

GlobalData Methodology 69

Additional Details

Publisher

Global Data

Publisher Information

Reference

230694 | GDHC5558CTIDB

Number of Pages

70

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Cholera - Pipeline Review, H2 2017
Cholera - Pipeline Review, H2 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcar...
18 Jul 2017 by Global Markets Direct USD $2,000 More Info
Cholera - Pipeline Insight, 2017
DelveInsight’s, “ Cholera -Pipeline Insights, 2017”, report provides comprehensive insights about pi...
10 Jul 2017 by Delve Insight USD $1,250 More Info
Cholera-Pipeline Insights, 2017
DelveInsight’s, “ Cholera-Pipeline Insights, 2017”, report provides in depth insights on the pipelin...
30 May 2017 by Delve Insight USD $1,250 More Info
Cholera-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2017
DelveInsight’s Report, “Cholera-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 20...
30 May 2017 by Delve Insight USD $2,000 More Info
Global Cholera Vaccine Market Research Report Forecast 2017 to 2021
The Global Cholera Vaccine Market Research Report Forecast 2017-2021 is a valuable source of insight...
15 May 2017 by S&P Consulting USD $2,800 More Info
Global Cholera Vaccines Market Research Report Forecast 2017 to 2021
The Global Cholera Vaccines Market Research Report Forecast 2017-2021 is a valuable source of insig...
10 May 2017 by S&P Consulting USD $2,800 More Info
Cholera - Pipeline Review, H1 2017
Cholera - Pipeline Review, H1 2017SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcar...
28 Feb 2017 by Global Markets Direct USD $2,000 More Info
Cholera Forecast for selected Asian Markets 2017-2027
Black Swan Analysis Epiomic™ Epidemiology Series Forecast Report on Cholera for Selected Asian Marke...
01 Jan 2017 by Black Swan Analysis USD $2,970 More Info
Cholera Global Clinical Trials Review, H2, 2016
Cholera Global Clinical Trials Review, H2, 2016SummaryGlobalData's clinical trial report, “Cholera G...
30 Nov 2016 by Global Data USD $2,500 More Info
Cholera Global Clinical Trials Review, H1, 2016
Cholera Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, “Cholera G...
29 Feb 2016 by Global Data USD $2,500 More Info

This report is published by Global Data

Download Free Report Summary PDF

Cholera Global Clinical Trials Review, H2, 2018 [Report Updated: 31-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data